
Keywords: NACT, neo-adjuvant chemotherapy; ACT, adjuvant chemotherapy; NCI, National Cancer Institute; CTCAE, Common Toxicity Criteria for Adverse Events; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; OR, odds ratios; CI, confidenc